Biologic therapy within a year of diagnosis could decrease risk for disease progression among patients with ulcerative ...
Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to ...
Vitamin D supplementation is linked to less disease activity and inflammation in inflammatory bowel disease and may restore ...
Genetic risk for inflammatory bowel disease could also help identify which patients will have a more severe disease ...
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal pain and diarrhea. Although current treatments, including 5-aminosalicylic ...
Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory disorder of the colon that follows a relapsing-remitting course. Characterised by mucosal inflammation, the disease requires accurate ...
Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conventional treatment options or tumor necrosis factor ...
Landmark VIVID-2 data showed more than 90% of patients who achieved steroid-free remission at one year maintained steroid-free control through three years Additional new data revealed exceptionally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results